Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tulipa edulis (Chinese name: 山慈姑) is a perennial bulbous plant in the Liliaceae family, native to East Asia and used in traditional Chinese medicine. The inner portion of its bulb is applied as an antidote, antipyretic (fever reducer), depurative (detoxifier), expectorant (promotes secretion of sputum), febrifuge (reduces fever), and laxative. It is mainly used as a poultice for ulcers and abscesses; the leaves are applied externally to treat abscesses and breast diseases. The flowers are sometimes used for dysuria treatment. There are reports of its use in cancer therapy within traditional practices[1][2][3][6]. Its mechanism appears to be based on general anti-inflammatory, detoxifying, antimicrobial effects typical of many medicinal bulbs rather than a specific molecular target identified by modern pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tulipa edulis.